Search This Blog

Monday, July 8, 2013

Eli Lilly and Company and Boehringer Ingelheim announce regulatory submission for new insulin glargine biosimilar product (NYSE:LLY)

Eli Lilly and Company and Boehringer Ingelheim announce regulatory submission for new insulin glargine biosimilar product (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.